| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2,4-dienoyl-CoA reductase 1 | 0.426 | 0.885 | 4.5E-14 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2012 | 2019 | ||||||||
|
5', 3'-nucleotidase, cytosolic | 0.729 | 0.231 | 2.7E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
5'-nucleotidase domain containing 3 | 0.821 | 0.192 | 1.5E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
5'-nucleotidase ecto | 0.436 | 0.885 | 2.3E-11 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2019 | ||||||||
|
5'-nucleotidase, cytosolic II | 0.537 | 0.846 | 2.1E-06 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2003 | 2011 | ||||||||
|
5'-nucleotidase, cytosolic IIIA | 0.593 | 0.692 | 1.5E-02 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2002 | 2014 | ||||||||
|
5-hydroxytryptamine receptor 1B | 0.551 | 0.769 | 0.19 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
5-methyltetrahydrofolate-homocysteine methyltransferase | 0.482 | 0.808 | 2.4E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 0.561 | 0.808 | 0.25 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
8-oxoguanine DNA glycosylase | 0.453 | 0.808 | 3.9E-12 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2010 | 2018 | ||||||||
|
A-kinase anchoring protein 12 | 0.566 | 0.615 | 3.6E-02 |
|
disease | 0.130 | None | 1.000 | 3 | 0 | 2004 | 2017 | ||||||||
|
A-kinase anchoring protein 13 | 0.626 | 0.615 | 0.93 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
A-kinase interacting protein 1 | 0.705 | 0.308 | 1.1E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
abl interactor 1 | 0.641 | 0.538 | 0.64 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2001 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.928 | 68 | 0 | 1989 | 2019 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2006 | 2019 | |||||||||
|
ABR activator of RhoGEF and GTPase | 0.650 | 0.500 | 0.63 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
acid phosphatase 3 | 0.525 | 0.731 | 2.5E-16 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2002 | ||||||||
|
acidic nuclear phosphoprotein 32 family member A | 0.674 | 0.577 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
acidic nuclear phosphoprotein 32 family member B | 0.541 | 0.731 | 0.96 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1987 | 2016 | ||||||||
|
activating signal cointegrator 1 complex subunit 1 | 0.495 | 0.846 | 2.6E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
activating transcription factor 1 | 0.588 | 0.577 | 0.63 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 |